Home › Calculator › HAE Dividend Calculator 2026
HAE Dividend DRIP Calculator 2026
2.60% YieldHealthcareHaemonetics Corporation · NYSE
Price: $76.89 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When HAE pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your HAE snowball 📈
$10,000 in HAE → $1.53M in 10 years · $22.55/month
About Haemonetics Corporation (HAE) — Dividend Analysis 2026
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center division provides advanced automated blood component and manual whole blood collection technologies. This includes MCS brand apheresis equipment for selectively collecting blood components, as well as disposable kits for whole blood collection and storage. Its software offerings feature the SafeTrace Tx blood bank information system and BloodTrack, a sophisticated suite of blood management software and hardware designed to enhance hospital blood bank functionalities and facilitate bedside transfusions. For the Hospital sector, Haemonetics offers hemostasis analyzer systems like TEG, ClotPro, and HAS, which deliver crucial assessments of a patient's overall clotting ability. The TEG Manager software links these analyzers throughout a facility, enabling clinicians to remotely access active and past test results to inform treatment decisions. Additionally, the Cell Saver Elite+ system supports autologous blood recovery across a wide range of surgical procedures, including cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological operations. The company distributes its products and solutions through its own direct sales teams, independent distributors, and sales representatives. Haemonetics Corporation was established in 1971 and is based in Boston, Massachusetts.
Compare HAE with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full HAE DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open HAE position with:
🌍 HAE Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold HAE.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.60% | -0.20% | $260 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.21% | -0.59% | $221 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.08% | -0.72% | $208 / yr |
| 🇬🇧 UK ISA | 0% | 2.60% | -0.20% | $260 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.37% | -0.43% | $237 / yr |
| 🇨🇦 TFSA | 0% | 2.60% | -0.20% | $260 / yr |
| 🇨🇦 CA Taxable | 25% | 1.95% | -0.85% | $195 / yr |
| 🇦🇺 Super (pension) | 15% | 2.21% | -0.59% | $221 / yr |
| 🇦🇺 AU Taxable | 30% | 1.82% | -0.98% | $182 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.91% | -0.89% | $191 / yr |
| 🇫🇷 FR Taxable | 30% | 1.82% | -0.98% | $182 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 HAE Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 HAE Dividend Payment Schedule
HAE pays quarterly — 4 times per year. Next ex-div: TBD.
📊 HAE vs Healthcare Benchmarks
How HAE compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HAE sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ HAE Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-06-05 | 259 | $71.28 | $18.5K | ||
| F-InKind | 2026-06-05 | 313 | $71.28 | $22.3K | ||
| A-Award | 2026-05-15 | 28,424 | — | — | ||
| F-InKind | 2026-05-15 | 2,913 | $56.29 | $164.0K | ||
| A-Award | 2026-05-15 | 27,535 | — | — | ||
| F-InKind | 2026-05-15 | 546 | $56.29 | $30.7K | ||
| A-Award | 2026-05-15 | 29,312 | — | — | ||
| F-InKind | 2026-05-15 | 2,505 | $56.29 | $141.0K | ||
| A-Award | 2026-05-15 | 2,220 | — | — | ||
| F-InKind | 2026-05-15 | 197 | $56.29 | $11.1K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where HAE earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HAE dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Haemonetics Corporation (HAE) is currently trading at $76.89, 41% below its 52-week high. The current dividend yield is 2.60% based on an annual payout of $2.00 per share.
HAE (Haemonetics Corporation) — 2.60% Dividend Yield Analysis
Haemonetics Corporation (HAE) is a healthcare stock currently trading at $76.89 with a dividend yield of 2.60%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.